Anticholinergic drugs are used in Ophthalmology because they produce what effect?
Pupil restriction.
Decreased lacrimal secretions.
Pupil dilation.
Sedation.
The Correct Answer is C
Choice A rationale
Anticholinergic drugs do not cause pupil restriction; they relax the muscles around the eye, leading to dilation.
Choice B rationale
Decreased lacrimal secretions are a secondary effect of anticholinergics and not their primary purpose in ophthalmology.
Choice C rationale
Anticholinergics cause pupil dilation (mydriasis) by relaxing the muscles that constrict the pupil, allowing for a better examination of the eye's interior.
Choice D rationale
Sedation is not a primary effect of anticholinergics used in ophthalmology.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
Parkinson's disease is characterized by an imbalance of dopamine and acetylcholine, primarily due to the degeneration of dopamine-producing neurons in the substantia nigra. This imbalance results in the characteristic motor symptoms of Parkinson's disease, such as tremors, rigidity, and bradykinesia.
Choice B rationale
Parkinson's disease involves decreased dopamine production, not increased. The disease is caused by the progressive loss of dopamine-producing neurons in the brain, leading to reduced dopamine levels and an imbalance with acetylcholine.
Choice C rationale
Alzheimer's disease is not primarily characterized by a decrease in dopamine. Instead, it involves the degeneration of cholinergic neurons and a deficiency in acetylcholine, which is crucial for memory and cognitive functions.
Choice D rationale
Alzheimer's disease is associated with a deficiency of acetylcholine rather than an excess. The disease is also characterized by the presence of neuritic plaques and neurofibrillary tangles in the brain, which contribute to cognitive decline.
Correct Answer is C
Explanation
Choice A rationale
Working with animals is typically done in preclinical trials before phase I studies in humans and is not part of phase III drug evaluation studies.
Choice B rationale
Conducting research to determine the effectiveness of the drug is part of phase II studies. Phase III studies focus more on confirming effectiveness, monitoring side effects, and comparing it to commonly used treatments.
Choice C rationale
Monitoring and observing patients closely for adverse effects is a key responsibility in phase III drug evaluation studies. These studies involve a larger patient population to gather comprehensive safety and efficacy data.
Choice D rationale
Choosing appropriate patients to be involved in the study is primarily the responsibility of researchers and clinicians during the earlier phases of drug development, such as phase I and phase II studies.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
